Skip to main content
SpringerLink
Log in

Vaccines against Morbillivirus Infections

  • Chapter
Veterinary Vaccines

Part of the book series: Progress in Vaccinology ((VACCINOLOGY,volume 4))

  • 178 Accesses

Abstract

Members of the genus Morbillivirus classified within the family of Paramyxoviridae are rinderpest virus (RPV), peste des petits ruminants (PPRV), canine distemper virus (CDV), and measles virus (MV) (16). Recently, other morbilliviruses have been isolated from aquatic mammals, like seals (phocid distemper virus, PDV) and dolphins (14,38). All viruses are highly contagious for their natural hosts and may cause serious, acute diseases that may result in high mortality rates. At present vaccination programs with live attenuated vaccines have proven to be the most effective approach to prevent RPV infection in cattle or domestic buffalo populations, PPRV infection in goats and sheep, CDV infection in dogs, and MV infection in humans. The use of live vaccines still has several disadvantages: they are less effective in the presence of maternal antibodies or intercurrent virus infections, may cause severe side-effects in immunocompromized hosts, and need a cold-chain during transport and storage. The use of live attenuated vaccines for use in wild species should not be advocated, as calamities in different wild species with live CDV vaccines have been reported (29). The introduction of Tween-ether- or formaldehyde-inactivated morbillivirus vaccines has been accompanied by serious problems. Animals or humans were shown to be insufficiently protected and in some cases illness following exposure to live virus was more severe than that in nonvaccinated individuals. As a result of new developments in biology and technology, also in the field of morbillivirus vaccines, the development is rapidly changing from the use of conventional methods to novel approaches for vaccine strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Appel MJG: Canine distemper virus. In: Horzinek MC (ed): Virus Infections of Vertebrates, Vol. 1. Amsterdam: Elsevier, 1987, pp 133–159.

    Google Scholar 

  2. Appel MJG, Gibbs EPJ, Martin SJ, et al: Morbillivirus diseases of animals and man In: Kurstak E (ed): Comparative Diagnosis of Viral Diseases, Vol. 4. Vertebrate Animal and Related Viruses. London: Academic Press, 1981, pp 235–297.

    Google Scholar 

  3. Appel M, Gillespie JH: Canine distemper virus. In: Gard S, Hallauer C, Meyer KF (ed): Virology Monographs 11. New York: Springer-Verlag, 1972, pp 1–96.

    Google Scholar 

  4. Appel MJG, Shek WR, Shesberadaran H, Norrby E: Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper. Arch Virol 1984; 82: 73–82.

    Article  PubMed  CAS  Google Scholar 

  5. Appel MJG, Shek WR, Summers BA: Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus. Infect Immun 1982; 37: 592–600.

    PubMed  CAS  Google Scholar 

  6. Arita I, Fenner F: Complication of smallpox vaccination. In: Quinnan J (ed): Vaccinia Viruses as Vectors for Vaccine Antigens. New York: Elsevier, 1985, pp 49–60.

    Google Scholar 

  7. Barrett T, Belsham GJ, Subbarao SM, Evans SA: Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus. Virology 1989; 170: 11–18.

    Article  PubMed  CAS  Google Scholar 

  8. Belsham GJ, Anderson EC, Murray PK, et al. Immune response and protection of cattle and pigs generated by a vaccinia virus recombinant expressing the F protein of rinderpest virus. Vet Rec 1989; 124: 655–658.

    Article  PubMed  CAS  Google Scholar 

  9. Curran MD, Clarke DK, Rima BK: The nucleotide sequence of the gene encoding the attachment protein H of canine distemper virus. J Gen Virol. 1991; 72: 443–447.

    Article  PubMed  CAS  Google Scholar 

  10. De Vries P, Van Binnendijk RS, Van der Marel P, et al: Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol 1988; 69: 549–559.

    Article  PubMed  Google Scholar 

  11. De Vries P, Uytde-Haag FGCM, Osterhaus ADME: Canine distemper virus (CDV) immune-stimulating complexes (iscoms), but not measles virus iscoms, protect dogs against CDV infection. J Gen Virol 1988; 69: 2071–2083.

    Article  PubMed  Google Scholar 

  12. De Vries P, Visser IKG, Groen J, et al: Immunogenicity of measles virus iscoms in the presence of passively transferred MV-specific antibodies. In: Vaccines 90: Modern Approaches to New Vaccines Including the Prevention of AIDS. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1990, pp 139–144.

    Google Scholar 

  13. Diallo A: Morbillivirus group: Genome organization and proteins. Vet Microbiol 1990; 23: 155–163.

    Article  PubMed  CAS  Google Scholar 

  14. Domingo M, Ferre L, Pumaorola M, et al: Morbillivirus in dolphins. Nature (London) 1990; 348: 21.

    Article  PubMed  CAS  Google Scholar 

  15. Drillien R, Spehner D, Kirn A, et al: Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proc Natl Acad Sci, USA 1988; 85: 1252–1256.

    Article  PubMed  CAS  Google Scholar 

  16. Fenner F: Paramyxoviridae. Intervirol 1976; 7: 59–60.

    Article  Google Scholar 

  17. Fraser KB, Martin SJ: Measles virus and its biology: Neuropathogenicity of measles virus. In: Twinsley TW, Brown F (eds): Experimental Virology. London: Academic Press, 1978, pp 118–137.

    Google Scholar 

  18. Fulginiti VA, Eller JJ, Downie AW: Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. J Am Med Assoc 1967; 202: 1075–1080.

    Article  CAS  Google Scholar 

  19. Grachev MA, Kumarev VP, Mamaev LV, et al: Distemper virus in Baikal seals. Nature (London) 1989; 338: 209.

    Article  Google Scholar 

  20. Höglund S, Dalsgaard K, Lövgren K, et al: ISCOMS and immunostimulation with viral antigens. In: Harris JR (ed): Subcellular Biochemistry, Vol. 15. New York: Plenum, 1989, pp 39–68.

    Google Scholar 

  21. Hsu D, Yamanaka M, Miller J, et al: Cloning of the fusion gens of rinderpest virus: Comparative sequence analysis with other morbilliviruses. Virology 1988; 166: 149–153.

    Article  PubMed  CAS  Google Scholar 

  22. Imagawa DT: Relationships among measles, canine distemper, and rinderpest viruses. Progr Med Virol 1968; 10: 160–193.

    CAS  Google Scholar 

  23. Jacobson S, Richert JR, Biddison WE, et al: Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol 1984; 133: 754–757.

    PubMed  CAS  Google Scholar 

  24. Katz SL, Enders JF• Immunization of children with a live attenuated measles vaccine. Am J Dis Child 1959; 86: 605.

    Google Scholar 

  25. Laidlaw PP, Dunkin GW: Studies in dog distemper. II. Experimental distemper in the dog. J Comp Pathol 1926; 39: 213–221.

    Google Scholar 

  26. Lucas CJ, Biddison WE, Nelson DL, Shaw S: Killing of measles virus-infected cells by human cytotoxic T cells. Infect Immun 1982; 38: 226–232.

    PubMed  CAS  Google Scholar 

  27. Mackett M, Smith GL: Vaccinia virus expression vectors. J Gen Virol 1986; 67: 2067–2082.

    Article  PubMed  CAS  Google Scholar 

  28. Meyer HM Jr, Brooks BE, Douglas RD, Rogers NG: Ecology of measles in monkeys. Am J Dis Child 1962; 103: 307–313.

    PubMed  Google Scholar 

  29. Montali RJ, Bartz CR, Bush M: Canine Distemper Virus. In: Horzinek MC (ed): Virus Infections of Vertebrates, Vol. 1. Amsterdam: Elsevier, 1987, pp 437–443.

    Google Scholar 

  30. Morein B, Simons K: Subunit vaccines against enveloped viruses: Virosomes, micelles and other protein complexes. Vaccine 1985; 3: 83–93.

    Article  PubMed  CAS  Google Scholar 

  31. Morein B, Sundquist B, Höglund S, et al: Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature (London) 1984; 308: 457–459.

    Article  PubMed  CAS  Google Scholar 

  32. Norrby E: Measles vaccination, today and tomorrow. Ann Inst Pasteur/ Virol 1985; 136E: 561–570.

    Article  Google Scholar 

  33. Norrby E, Appel MJG: Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus. Arch Virol 1980; 66: 169–170.

    Article  PubMed  CAS  Google Scholar 

  34. Norrby E, Enders-Ruckle G, Ter Meulen V: Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis 1975; 132: 262–269.

    Article  PubMed  CAS  Google Scholar 

  35. Norrby E, Sheshberadaran H, McCullough KC, et al: Is rinderpest virus the archevirus of the Morbillivirus genus? Intervirology 1985; 23: 228–232.

    Article  PubMed  CAS  Google Scholar 

  36. Norrby E, Utter G, Orvell C, Appel M: Protection against canine distemper virus in dogs after immunization with isolated fusion protein. J Virol 1986; 58: 536–541.

    PubMed  CAS  Google Scholar 

  37. Örvell C, Norrby E: Antigenic structure of paramyxoviruses. In: Van Regenmortel MHV, Neurath AR (eds): Immunochemistry of Viruses: The Basis for Seriodiagnosis and Vaccines. Amsterdam: Elsevier, 1985, pp 241–264.

    Google Scholar 

  38. Osterhaus ADME, Groen J, Spijkers HEM et al: Mass mortality in seals caused by a newly discovered morbillivirus. J Vet Microbiol 1990; 23: 343–350.

    Article  CAS  Google Scholar 

  39. Osterhaus ADME, Groen J, UytdeHaag FGCM: Distemper virus in Baikal seals. Nature (London) 1989; 338: 209–210.

    Article  Google Scholar 

  40. Osterhaus ADME, UytdeHaag FGCM, Visser IKG, et al: Seal vaccination success. Nature (London) 1989; 337: 21.

    Article  PubMed  CAS  Google Scholar 

  41. Osterhaus ADME, Visser IKG, Swart RL de, et al: Morbillivirus threat to Mediterranean monk seals? Vet Rec 1992; 130: 141–142.

    Article  PubMed  CAS  Google Scholar 

  42. Pearson RC, Gorham JR: Canine Distemper Virus. In: Horzinek MC (ed): Virus Infections of Vertebrates, Vol. 1. Amsterdam: Elsevier, 1987, pp 371–378.

    Google Scholar 

  43. Plowright W: Rinderpest virus. Virology Monographs No. 3. Vienna: Springer-Verlag, 1968.

    Google Scholar 

  44. Rima BK: The proteins of morbilliviruses. J Gen Virol 1983; 64: 1205–1219.

    Article  PubMed  CAS  Google Scholar 

  45. Rockborn G: A preliminary report on efforts to produce a living distemper vaccine in tissue culture. J Small Anim Pract 1960; 1: 53.

    Article  Google Scholar 

  46. Scott GR: Rinderpest virus. In: Horzinek MC (ed): Virus Infections of Ruminants, Vol. 3. Amsterdam: Elsevier, 1990, pp 341–354.

    Google Scholar 

  47. Scott GR: Peste-des-petits-ruminants (goat plague) virus. In: Horzinek MC (ed): Virus Infections of Ruminants, Vol. 3. Amsterdam: Elsevier, 1990, pp 355–361.

    Google Scholar 

  48. Takahashi H, Takeshita T, Morein B, et al: Induction of CD8+ cytotoxic T cels by immunization with purified HIV-1 envelope protein in iscoms. Nature (London) 1990; 344: 873–875.

    Article  PubMed  CAS  Google Scholar 

  49. Trudgett A, Lyons C, Welsh MJ, et al: Analysis of a seal and a porpoise morbillivirus using monoclonal antibodies. Vet Rec 1991; 128: 61.

    Article  PubMed  CAS  Google Scholar 

  50. Tsukiyama K, Yoshikawa Y, Kamata H, et al: Development of heat-stable recombinant rinderpest vaccine. Arch Virol 1989; 107: 225–235.

    Article  PubMed  CAS  Google Scholar 

  51. Van Binnendijk RS, Poelen MCM, Kuijpers K, et al: The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC restricted cytotoxic T lymphocytes (CTL) in recovery from measles: Clonal analyses of human CD8+ class I MHC restricted CTL. J Immunol 1990; 144: 2394–2399.

    PubMed  Google Scholar 

  52. Van Binnendijk RS, Poelen MCM, De Vries P, et al: Measles virus-specific human T cell clones: characterization of specificity and function of CD +4 helper/cytotoxic and CD +8 cytotoxic T cell clones. J Immunol 1989; 142: 2847–2854.

    PubMed  Google Scholar 

  53. Van Binnendijk RS, Poelen MCM, De Vries P, et al: A role for CD8+ class I MHC-restricted CTLs in recovery from measles: Implications for the development of inactivated measles vaccines. In: Vaccines 91: Proceedings of the Meeting “Modern Approaches to New Vaccines Including the Prevention of AIDS,” 12–16 September 1990. Gold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1991; pp 299–303.

    Google Scholar 

  54. Van Bressem MF, Visser IKG, Van De Bildt MWG, et al: Morbillivirus infection in Mediterranean striped dolphins (Stenella coeruleoalba). Vet Rec 1991; 129: 471–472.

    Article  PubMed  Google Scholar 

  55. Varsanyi TM, Morein B, Love A, Norrby E: Protection against lethal measles virus infection in mice by immune stimulating complexes containing the haemagglutinin of fusion protein. J Virol 1987; 61: 3896–3901.

    PubMed  CAS  Google Scholar 

  56. Visser IKG, Kumarev VP, Örvell C, et al: Comparison of two morbilliviruses isolated from seals during outbreaks of distemper in North West Europe and Siberia. Arch Virol 1990; 111: 149–164.

    Article  PubMed  CAS  Google Scholar 

  57. Visser IKG, Van de Bildt MWG, Brugge HN, et al: Vaccination of harbour seals (Phoca vitulina) against phocid distemper with two different inactivated canine distemper virus (CDV) vaccines. Vaccine 1989; 7: 521–526.

    Article  PubMed  CAS  Google Scholar 

  58. Yamanaka M, Hsu D, Crisp T, et al: Cloning and sequence analysis of the hemagglutinin gene of the virulent strain of rinderpest virus. Virology 1988; 166: 251–253.

    Article  PubMed  CAS  Google Scholar 

  59. Yamanouchi K: Comparative aspects of pathogenicity of measles canine distemper and rinderpest viruses. Jpn J Med Sci Biol 1980; 33: 41–66.

    PubMed  CAS  Google Scholar 

  60. Yilma T, Hsu D, Jones J, et al: Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science 1988; 242: 1058–1061.

    Article  PubMed  CAS  Google Scholar 

  61. Van Bennendy, et al: Exp Med 1992; 176: in press.

    Google Scholar 

Download references

Authors
  1. Petra de Vries
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert D. M. E. Osterhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Veterinary Microbiology College of Veterinary Sciences, Haryana Agricultural University, 125 004, Hisar, India

    R. Pandey  & G. Prasad  & 

  2. Department of Biochemistry Biomedical Center, University of Uppsala, P.O. Box 576, 5-757 23, Uppsala, Sweden

    S. Höglund

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

de Vries, P., Osterhaus, A.D.M.E. (1993). Vaccines against Morbillivirus Infections. In: Pandey, R., Höglund, S., Prasad, G. (eds) Veterinary Vaccines. Progress in Vaccinology, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9226-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-9226-2_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-9228-6

  • Online ISBN: 978-1-4613-9226-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation